Animal models of idiosyncratic drug reactions.
暂无分享,去创建一个
[1] L. Trepanier,et al. Cytosolic arylamine N-acetyltransferase (NAT) deficiency in the dog and other canids due to an absence of NAT genes. , 1997, Biochemical pharmacology.
[2] P. Bigazzi. Autoimmunity induced by chemicals. , 1988, Journal of toxicology. Clinical toxicology.
[3] J. Uetrecht,et al. Tolerance induced by low dose D-penicillamine in the brown Norway rat model of drug-induced autoimmunity is immune-mediated. , 2004, Chemical Research in Toxicology.
[4] S P Spielberg,et al. Adverse reactions to sulphonamide and sulphonamide-trimethoprim antimicrobials: clinical syndromes and pathogenesis. , 1996, Adverse drug reactions and toxicological reviews.
[5] E. Reynolds,et al. Halothane hepatotoxicity: enhancement by polychlorinated biphenyl pretreatment. , 1977 .
[6] T. Rushmore,et al. Halothane-induced liver injury in outbred guinea pigs: role of trifluoroacetylated protein adducts in animal susceptibility. , 2001, Chemical research in toxicology.
[7] Steven D. Cohen,et al. Reduced hepatotoxicity of acetaminophen in mice lacking inducible nitric oxide synthase: potential role of tumor necrosis factor-alpha and interleukin-10. , 2002, Toxicology and Applied Pharmacology.
[8] R. N. Brogden,et al. Ranitidine. An updated review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in peptic ulcer disease and other allied diseases. , 1989, Drugs.
[9] J. Cook,et al. Molecular mechanisms of endotoxin tolerance. , 2004, Journal of endotoxin research.
[10] D. Vergani,et al. Antibodies to the surface of halothane-altered rabbit hepatocytes in patients with severe halothane-associated hepatitis. , 1980, The New England journal of medicine.
[11] J. Luyendyk,et al. Ranitidine Treatment during a Modest Inflammatory Response Precipitates Idiosyncrasy-Like Liver Injury in Rats , 2003, Journal of Pharmacology and Experimental Therapeutics.
[12] L. Trepanier,et al. Evaluation of the clinical, immunologic, and biochemical effects of nitroso sulfamethoxazole administration to dogs: a pilot study. , 2005, Toxicology.
[13] L. Wei,et al. Transgenic animals as new approaches in pharmacological studies. , 1997, Annual review of pharmacology and toxicology.
[14] J. Bousquet,et al. Epidemiology of drug allergy , 2001, Current opinion in allergy and clinical immunology.
[15] J. Renard,et al. Generation of Fertile Cloned Rats by Regulating Oocyte Activation , 2003, Science.
[16] J. Brady,et al. A protective role for cyclooxygenase-2 in drug-induced liver injury in mice. , 2001, Chemical research in toxicology.
[17] A. Hurvitz,et al. Propylthiouracil-associated hemolytic anemia, thrombocytopenia, and antinuclear antibodies in cats with hyperthyroidism. , 1984, Journal of the American Veterinary Medical Association.
[18] J. Uetrecht,et al. Antibodies to myeloperoxidase in propylthiouracil-induced autoimmune disease in the cat. , 1996, Toxicology.
[19] J. Ward,et al. Effect of indoleamine 2,3-dioxygenase on induction of experimental autoimmune encephalomyelitis , 2002, Journal of Neuroimmunology.
[20] K. Landsteiner,et al. STUDIES ON THE SENSITIZATION OF ANIMALS WITH SIMPLE CHEMICAL COMPOUNDS , 1935, The Journal of experimental medicine.
[21] D. Dieterich,et al. Drug-induced liver injury associated with the use of nonnucleoside reverse-transcriptase inhibitors. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[22] M. Manns,et al. Experimental autoimmune hepatitis: Disease induction, time course and t‐cell reactivity , 1990, Hepatology.
[23] L. Pohl,et al. Role of interleukin-6 in hepatic heat shock protein expression and protection against acetaminophen-induced liver disease. , 2003, Biochemical and biophysical research communications.
[24] B B Brodie,et al. Acetaminophen-induced hepatic necrosis. I. Role of drug metabolism. , 1973, The Journal of pharmacology and experimental therapeutics.
[25] T. Macdonald,et al. A mechanistic approach to understanding species differences in felbamate bioactivation: relevance to drug-induced idiosyncratic reactions. , 2000, Drug metabolism and disposition: the biological fate of chemicals.
[26] L. Trepanier,et al. Clinical findings in 40 dogs with hypersensitivity associated with administration of potentiated sulfonamides. , 2003, Journal of veterinary internal medicine.
[27] Martyn T. Smith,et al. Mechanisms of troglitazone hepatotoxicity. , 2003, Chemical research in toxicology.
[28] E. Bardana,et al. Systemic lupus erythematosus-like syndrome in monkeys fed alfalfa sprouts: role of a nonprotein amino acid. , 1982, Science.
[29] P. Hultman,et al. Methyl mercury-induced autoimmunity in mice. , 1999, Toxicology and applied pharmacology.
[30] J. Uetrecht,et al. New concepts in immunology relevant to idiosyncratic drug reactions: the "danger hypothesis" and innate immune system. , 1999, Chemical research in toxicology.
[31] Modulation of macrophage functioning abrogates the acute hepatotoxicity of acetaminophen , 1995, Hepatology.
[32] A. Y. Lu,et al. N-acetyl-p-benzoquinone imine: a cytochrome P-450-mediated oxidation product of acetaminophen. , 1984, Proceedings of the National Academy of Sciences of the United States of America.
[33] E. Shevach,et al. Control of T‐cell activation by CD4+ CD25+ suppressor T cells , 2001, Immunological reviews.
[34] R. Hu,et al. Production of knockout rats using ENU mutagenesis and a yeast-based screening assay , 2003, Nature Biotechnology.
[35] H. Zimmerman,et al. Hepatotoxicity: The adverse effects of drugs and other chemicals on the liver , 1978 .
[36] S. Sherlock,et al. HALOTHANE-RELATED HEPATITIS , 1975 .
[37] Steven D. Cohen,et al. A comparative study of mouse liver proteins arylated by reactive metabolites of acetaminophen and its nonhepatotoxic regioisomer, 3'-hydroxyacetanilide. , 1995, Chemical research in toxicology.
[38] L. Trepanier. Delayed hypersensitivity reactions to sulphonamides: syndromes, pathogenesis and management. , 1999, Veterinary dermatology.
[39] R. Meyboom,et al. Agranulocytosis induced by propylthiouracil: evidence of a drug dependent antibody reacting with granulocytes, monocytes and haematopoietic progenitor cells , 1986, British journal of haematology.
[40] J. Uetrecht,et al. N-OXIDATION OF DRUGS ASSOCIATED WITH IDIOSYNCRATIC DRUG REACTIONS , 2002, Drug metabolism reviews.
[41] S. Rana,et al. Study of oxidative-stress in isoniazid-rifampicin induced hepatic injury in young rats. , 1997, Drug and chemical toxicology.
[42] D. Doniach,et al. Unexplained hepatitis following halothane. , 1976, Anesthesiology.
[43] A. J. Gandolfi,et al. A Model for Fatal Halothane Hepatitis in the Guinea Pig , 1994, Anesthesiology.
[44] J. Uetrecht,et al. Modulation of D-penicillamine-induced autoimmunity in the Brown Norway rat using pharmacological agents that interfere with arachidonic acid metabolism or synthesis of inducible nitric oxide synthase. , 2003, Toxicology.
[45] J. Oates,et al. Metabolism of procainamide to a hydroxylamine by rat and human hepatic microsomes. , 1984, Drug metabolism and disposition: the biological fate of chemicals.
[46] P. Mehta,et al. Immunologic Consequences of Taurine Deficiency in Cats , 1990, Journal of leukocyte biology.
[47] J. Uetrecht,et al. Contrasting Effects on Halothane Hepatotoxicity in the Phenobarbital-Hypoxia and Triiodothyronine Model: Mechanistic Implications , 1983, Anesthesiology.
[48] B. Ryffel,et al. Use of transgenic animals to investigate drug hypersensitivity. , 2001, Toxicology.
[49] L. Trepanier. Idiosyncratic toxicity associated with potentiated sulfonamides in the dog. , 2004, Journal of veterinary pharmacology and therapeutics.
[50] R. Stern,et al. Severe adverse cutaneous reactions to drugs. , 1994, The New England journal of medicine.
[51] A. J. Gandolfi,et al. Demonstration of a cellular immune response in halothane-exposed guinea pigs. , 1997, Toxicology and applied pharmacology.
[52] S Hanash,et al. Evidence for impaired T cell DNA methylation in systemic lupus erythematosus and rheumatoid arthritis. , 1990, Arthritis and rheumatism.
[53] A. Cribb. Idiosyncratic reactions to sulfonamides in dogs. , 1989, Journal of the American Veterinary Medical Association.
[54] C. Epstein,et al. Characterization of the antioxidant status of the heterozygous manganese superoxide dismutase knockout mouse. , 1999, Archives of biochemistry and biophysics.
[55] C. W. Parker. Allergic reactions in man. , 1982, Pharmacological reviews.
[56] N. Kitteringham,et al. Immunogenicity of amodiaquine in the rat. , 1990, International archives of allergy and applied immunology.
[57] C. Moore,et al. Predisposition to nevirapine hypersensitivity associated with HLA-DRB1*0101 and abrogated by low CD4 T-cell counts , 2005, AIDS.
[58] B. Richardson. DNA methylation and autoimmune disease. , 2003, Clinical immunology.
[59] D. Wallace,et al. Dubois' Lupus Erythematosus , 1987 .
[60] P. Venables,et al. Drug-Induced Lupus , 1995, Drug safety.
[61] Dominic P. Williams,et al. Disposition of amodiaquine and related antimalarial agents in human neutrophils: implications for drug design. , 1997, The Journal of pharmacology and experimental therapeutics.
[62] L. Pohl,et al. Protection against acetaminophen‐induced liver injury and lethality by interleukin 10: Role of inducible nitric oxide synthase , 2002, Hepatology.
[63] J. Timbrell,et al. Isoniazid and iproniazid: activation of metabolites to toxic intermediates in man and rat. , 1976, Science.
[64] P. Matzinger. Tolerance, danger, and the extended family. , 1994, Annual review of immunology.
[65] H. Robinson,et al. Adverse effects of D-penicillamine in rheumatoid arthritis. , 1980, Annals of internal medicine.
[66] C. D. Thompson,et al. Identification of modified atropaldehyde mercapturic acids in rat and human urine after felbamate administration. , 1997, Chemical research in toxicology.
[67] J. Waring,et al. Microarray Analysis of Lipopolysaccharide Potentiation of Trovafloxacin-Induced Liver Injury in Rats Suggests a Role for Proinflammatory Chemokines and Neutrophils , 2006, Journal of Pharmacology and Experimental Therapeutics.
[68] A. J. Gandolfi,et al. Trifluoroacetylation potentiates the humoral immune response to halothane in the guinea pig. , 1995, Immunopharmacology and immunotoxicology.
[69] N. Kitteringham,et al. The mechanism of bioactivation and antigen formation of amodiaquine in the rat. , 1992, Biochemical pharmacology.
[70] J. Uetrecht,et al. A comparison of the oxidation of clozapine and olanzapine to reactive metabolites and the toxicity of these metabolites to human leukocytes. , 1998, Molecular pharmacology.
[71] S. Wolfe,et al. Timing of new black box warnings and withdrawals for prescription medications. , 2002, JAMA.
[72] A. Sehon,et al. Evaluation of isoniazid-associated hepatitis by immunological tests. , 1978, Clinical and experimental immunology.
[73] W. Santos,et al. Role of glutathione S-transferases A1-1, M1-1, and P1-1 in the detoxification of 2-phenylpropenal, a reactive felbamate metabolite. , 2001, Chemical research in toxicology.
[74] C. D. Thompson,et al. Synthesis and in vitro reactivity of 3-carbamoyl-2-phenylpropionaldehyde and 2-phenylpropenal: putative reactive metabolites of felbamate. , 1996, Chemical research in toxicology.
[75] M. Cousins,et al. Guinea-pig model of halothane-associated hepatotoxicity in the absence of enzyme induction and hypoxia. , 1985, The Journal of pharmacology and experimental therapeutics.
[76] B. K. Park,et al. The bioactivation of amodiaquine by human polymorphonuclear leucocytes in vitro: chemical mechanisms and the effects of fluorine substitution. , 1995, Biochemical pharmacology.
[77] T. Mittag,et al. d-Penicillamine-induced neuromuscular disease in guinea pigs , 1982, Experimental Neurology.
[78] K. Wagner,et al. [Agranulocytosis due to the occurrence of leukocyte-agglutinins; pyramidon and cold agglutinins]. , 1952, Acta haematologica.
[79] W. G. Lai. Bioactivation of trimethoprim, fluperlapine and nevirapine, roles of iminoquinone-type Michael acceptors in idiosyncratic drug reactions , 2000 .
[80] A. Kretz-Rommel,et al. Autoimmunity caused by disruption of central T cell tolerance. A murine model of drug-induced lupus. , 1997, The Journal of clinical investigation.
[81] M. Dowsett,et al. Agranulocytosis associated with aminoglutethimide: pharmacological and marrow studies. , 1986, British Journal of Cancer.
[82] N. Pumford,et al. Pretreatment of mice with macrophage inactivators decreases acetaminophen hepatotoxicity and the formation of reactive oxygen and nitrogen species , 1999, Hepatology.
[83] J. Uetrecht,et al. Clozapine is oxidized by activated human neutrophils to a reactive nitrenium ion that irreversibly binds to the cells. , 1995, The Journal of pharmacology and experimental therapeutics.
[84] Toshiharu Horie,et al. Involvement of mitochondrial permeability transition in acetaminophen-induced liver injury in mice. , 2005, Journal of hepatology.
[85] K. Lange. Nephropathy induced by D-penicillamine. , 1978, Contributions to nephrology.
[86] D. Wallace,et al. Increased mitochondrial oxidative stress in the Sod2 (+/−) mouse results in the age-related decline of mitochondrial function culminating in increased apoptosis , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[87] C. Noli,et al. A retrospective evaluation of adverse reactions to trimethoprim-sulphonamide combinations in dogs and cats. , 1995, The Veterinary quarterly.
[88] U. Giger,et al. Sulfadiazine-induced allergy in six Doberman pinschers. , 1985, Journal of the American Veterinary Medical Association.
[89] M. Monestier,et al. Cytokine regulation of a rodent model of mercuric chloride-induced autoimmunity. , 1999, Environmental health perspectives.
[90] P. Ganey,et al. Is exposure to bacterial endotoxin a determinant of susceptibility to intoxication from xenobiotic agents? , 1997, Toxicology and applied pharmacology.
[91] B. R. Brown,et al. An Animal Model of Hepatotoxicity Associated with Halothane Anesthesia , 1976, Anesthesiology.
[92] B. Richardson,et al. Mechanisms of drug-induced lupus. IV. Comparison of procainamide and hydralazine with analogs in vitro and in vivo. , 1997, Arthritis and rheumatism.
[93] O. H. Setty,et al. Protective effect of Phyllanthus fraternus against carbon tetrachloride-induced mitochondrial dysfunction. , 1999, Life sciences.
[94] R. Pollard,et al. Safety profile of nevirapine, a nonnucleoside reverse transcriptase inhibitor for the treatment of human immunodeficiency virus infection. , 1998, Clinical therapeutics.
[95] D. Horn,et al. Fialuridine is phosphorylated and inhibits DNA synthesis in isolated rat hepatic mitochondria. , 1997, Antiviral research.
[96] W. Pichler. Pharmacological interaction of drugs with antigen-specific immune receptors: the p-i concept , 2002, Current opinion in allergy and clinical immunology.
[97] M. Pastore,et al. Serum Transaminases in Children with Wilson’s Disease , 2004, Journal of pediatric gastroenterology and nutrition.
[98] D. Laskin,et al. Exaggerated hepatotoxicity of acetaminophen in mice lacking tumor necrosis factor receptor-1. Potential role of inflammatory mediators. , 2003, Toxicology and applied pharmacology.
[99] P. Hultman,et al. Dose-response studies in murine mercury-induced autoimmunity and immune-complex disease. , 1992, Toxicology and applied pharmacology.
[100] A. Elkahloun,et al. Macrophage migration inhibitory factor in drug-induced liver injury: a role in susceptibility and stress responsiveness. , 2002, Biochemical and biophysical research communications.
[101] R. McClelland,et al. Oxidation of aminopyrine by hypochlorite to a reactive dication: possible implications for aminopyrine-induced agranulocytosis. , 1995, Chemical Research in Toxicology.
[102] D. Drayer,et al. Propylthiouracil-induced immune-mediated disease in the cat. , 1985, The Journal of pharmacology and experimental therapeutics.
[103] D. Burley,et al. Aminoglutethimide : a ' side-effect ' turned to therapeutic advantage , 2008 .
[104] Zhiyong Zhang,et al. Hydralazine may induce autoimmunity by inhibiting extracellular signal-regulated kinase pathway signaling. , 2003, Arthritis & Rheumatism.
[105] D. Laskin,et al. Role of macrophages and inflammatory mediators in chemically induced toxicity. , 2001, Toxicology.
[106] T. Pollmächer,et al. Effects of antipsychotic drugs on cytokine networks. , 2000, Journal of psychiatric research.
[107] J. Leeder,et al. A comparison of the covalent binding of clozapine and olanzapine to human neutrophils in vitro and in vivo. , 1998, Molecular pharmacology.
[108] G. Cocconi. First generation aromatase inhibitors — aminoglutethimide and testololactone , 2004, Breast Cancer Research and Treatment.
[109] M. Popović,et al. Evidence of an immune-mediated mechanism for an idiosyncratic nevirapine-induced reaction in the female Brown Norway rat. , 2005, Chemical research in toxicology.
[110] A. Donker,et al. Effects of prolonged administration of D-penicillamine or captopril in various strains of rats. Brown Norway rats treated with D-penicillamine develop autoantibodies, circulating immune complexes, and disseminated intravascular coagulation. , 1984, Clinical immunology and immunopathology.
[111] J. Uetrecht,et al. Factors that modify penicillamine-induced autoimmunity in Brown Norway rats: failure of the Th1/Th2 paradigm. , 2001, Toxicology.
[112] E. Amento,et al. Mechanisms of drug-induced lupus. II. T cells overexpressing lymphocyte function-associated antigen 1 become autoreactive and cause a lupuslike disease in syngeneic mice. , 1996, The Journal of clinical investigation.
[113] P. Goss,et al. Metabolism of aminoglutethimide in humans: quantification and clinical relevance of induced metabolism. , 1985, British Journal of Cancer.
[114] W. Evering,et al. Atypical antipsychotic-induced neutropenia in dogs. , 1999, Toxicology and applied pharmacology.
[115] S. Hanash,et al. Hydralazine and procainamide inhibit T cell DNA methylation and induce autoreactivity. , 1988, Journal of immunology.
[116] B. Guilbert,et al. Experimental gold-induced autoimmunity. , 1991, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[117] H. Jick. Adverse reactions to trimethoprim-sulfamethoxazole in hospitalized patients. , 1982, Reviews of infectious diseases.
[118] G. Ansari,et al. Trichloroethene-induced autoimmune response in female MRL +/+ mice. , 1995, Toxicology and applied pharmacology.
[119] T. Misteli,et al. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation , 2002, Nature.
[120] W. Kean,et al. D-penicillamine: chemistry and clinical use in rheumatic disease. , 1986, Seminars in arthritis and rheumatism.
[121] C. Lang,et al. Hepatic Necrosis Produced by Repeated Administration of Halothane to Guinea Pigs , 1972, Anesthesiology.
[122] J. Bruijn,et al. Immunological alterations inducible by mercury compounds. III. H‐2A acts as an immune response and H‐2E as an immune “suppression” locus for HgCl2‐induced antinucleolar autoantibodies , 1989, European journal of immunology.
[123] M. Matzuk,et al. Neurodegeneration, myocardial injury, and perinatal death in mitochondrial superoxide dismutase-deficient mice. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[124] S. Adams,et al. Inhibition of isoniazid-induced hepatotoxicity in rabbits by pretreatment with an amidase inhibitor. , 1999, The Journal of pharmacology and experimental therapeutics.
[125] J. Rhodes. Evidence for an intercellular covalent reaction essential in antigen-specific T cell activation. , 1989, Journal of immunology.
[126] R. Burlingame,et al. IgG but not other classes of anti-[(H2A-H2B)-DNA] is an early sign of procainamide-induced lupus. , 1995, Journal of immunology.
[127] J. Uetrecht,et al. Investigation of the Involvement of Macrophages and T Cells in D-Penicillamine-Induced Autoimmunity in the Brown Norway Rat , 2004, Journal of immunotoxicology.
[128] J. Uetrecht. The role of leukocyte-generated reactive metabolites in the pathogenesis of idiosyncratic drug reactions. , 1992, Drug metabolism reviews.
[129] J. Uetrecht,et al. Oxidation of propylthiouracil to reactive metabolites by activated neutrophils. Implications for agranulocytosis. , 1991, Drug metabolism and disposition: the biological fate of chemicals.
[130] N. M. Ferguson,et al. Attempts at induced agranulocytosis in rats using dipyrone. , 1966, Journal of pharmaceutical sciences.
[131] R. Warrington,et al. The predictive value of the lymphocyte transformation test in isoniazid‐associated hepatitis , 1982, Clinical allergy.
[132] R. Sofia,et al. Acute, subchronic, and chronic toxicity studies with felbamate, 2-phenyl-1,3-propanediol dicarbamate. , 1998, Toxicological sciences : an official journal of the Society of Toxicology.
[133] Y. Shoenfeld,et al. Animal Models of Systemic Lupus Erythematosus , 1994 .
[134] Z. Husain,et al. Felbamate-induced apoptosis of hematopoietic cells is mediated by redox-sensitive and redox-independent pathways , 2002, Epilepsy Research.
[135] C. Bosman,et al. Mercuric chloride-induced autoimmunity in the brown Norway rat. Cellular kinetics and major histocompatibility complex antigen expression. , 1988, The American journal of pathology.
[136] E. Morgan. Regulation of cytochrome p450 by inflammatory mediators: why and how? , 2001, Drug metabolism and disposition: the biological fate of chemicals.
[137] Lisa M. D'Souza,et al. Genome sequence of the Brown Norway rat yields insights into mammalian evolution , 2004, Nature.
[138] B. Richardson,et al. Mechanism of drug-induced lupus. I. Cloned Th2 cells modified with DNA methylation inhibitors in vitro cause autoimmunity in vivo. , 1995, Journal of immunology.
[139] I. Guest,et al. Examination of possible toxic and immune mechanisms of clozapine-induced agranulocytosis. , 1998, Toxicology.
[140] D. Aucoin,et al. Altered disposition of propylthiouracil in cats with hyperthyroidism. , 1988, Research in veterinary science.
[141] T. Greenough,et al. High-dose nevirapine: safety, pharmacokinetics, and antiviral effect in patients with human immunodeficiency virus infection. , 1995, The Journal of infectious diseases.
[142] W. Seinen,et al. Autoimmunity and Toxicology: Immune Disregulation Induced by Drugs and Chemicals , 1989 .
[143] H. Cedar,et al. Effect of regional DNA methylation on gene expression. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[144] R. Rubin,et al. Drug-induced lupus. , 2005, Toxicology.
[145] U. Boelsterli. Animal models of human disease in drug safety assessment. , 2003, The Journal of toxicological sciences.
[146] S. Gaffen,et al. Interleukin‐17 regulates expression of the CXC chemokine LIX/CXCL5 in osteoblasts: implications for inflammation and neutrophil recruitment , 2004, Journal of leukocyte biology.
[147] K. Neftel,et al. Detection of antidrug IgG antibodies in patients with adverse drug reactions to amodiaquine. , 1991, International archives of allergy and applied immunology.
[148] E. Gez,et al. Aminoglutethimide-induced leukopenia: a case report and review of the literature. , 1984, Oncology.
[149] D. Drayer,et al. Dose-dependent induction of anti-native DNA antibodies in cats by propylthiouracil. , 1988, Arthritis and rheumatism.
[150] J. Cook,et al. Review: Molecular mechanisms of endotoxin tolerance , 2004 .
[151] I. Egorov,et al. Mercuric chloride-, gold sodium thiomalate-, and D-penicillamine-induced antinuclear antibodies in mice. , 1986, Toxicology and applied pharmacology.
[152] M. Abu-Asab,et al. Characterization of a potential animal model of an idiosyncratic drug reaction: nevirapine-induced skin rash in the rat. , 2003, Chemical research in toxicology.
[153] S. Adams,et al. Role of hydrazine in the mechanism of isoniazid hepatotoxicity in rabbits , 1996, Archives of Toxicology.
[154] U. Thorgeirsson,et al. Isoniazid liver injury: clinical spectrum, pathology, and probable pathogenesis. , 1976, Annals of internal medicine.
[155] W. Santos,et al. Interaction between human serum albumin and the felbamate metabolites 4-Hydroxy-5-phenyl-[1,3]oxazinan-2-one and 2-phenylpropenal. , 2002, Chemical research in toxicology.
[156] I. Jaffe. Induction of auto-immune syndromes by penicillamine therapy in rheumatoid arthritis and other diseases , 2005, Springer Seminars in Immunopathology.
[157] P. Bigazzi,et al. Autoimmunity caused by xenobiotics. , 1997, Toxicology.
[158] W. Miller,et al. Sex differences in nevirapine rash. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[159] R. Pieters,et al. Investigating the role of 2-phenylpropenal in felbamate-induced idiosyncratic drug reactions. , 2004, Chemical research in toxicology.
[160] D. Pessayre,et al. Homozygosity for alanine in the mitochondrial targeting sequence of superoxide dismutase and risk for severe alcoholic liver disease. , 2001, Gastroenterology.
[161] K. Neftel,et al. Amodiaquine induced agranulocytosis and liver damage. , 1986, British medical journal.
[162] B B Brodie,et al. Acetaminophen-induced hepatic necrosis. II. Role of covalent binding in vivo. , 1973, The Journal of pharmacology and experimental therapeutics.
[163] M Pirmohamed,et al. Induction of metabolism-dependent and -independent neutrophil apoptosis by clozapine. , 2000, Molecular pharmacology.
[164] A. Poole,et al. Comparison of in vitro and in vivo haemotoxic effects of aminoglutethimide and glutethimide. , 1990, Toxicology in vitro : an international journal published in association with BIBRA.
[165] A. Montanaro,et al. Dietary amino acid-induced systemic lupus erythematosus. , 1991, Rheumatic diseases clinics of North America.
[166] A. Breckenridge,et al. Drug-protein conjugates--XVIII. Detection of antibodies towards the antimalarial amodiaquine and its quinone imine metabolite in man and the rat. , 1989, Biochemical pharmacology.
[167] T. Baillie,et al. Drug-protein adducts: an industry perspective on minimizing the potential for drug bioactivation in drug discovery and development. , 2004, Chemical research in toxicology.
[168] J. Brady,et al. Protective role of Kupffer cells in acetaminophen-induced hepatic injury in mice. , 2002, Chemical research in toxicology.
[169] J. Park,et al. Anti-IL-4 monoclonal antibody prevents antibiotics-induced active fatal anaphylaxis. , 1997, Journal of immunology.
[170] N. Kitteringham,et al. Drug-protein conjugates--XIV. Mechanisms of formation of protein-arylating intermediates from amodiaquine, a myelotoxin and hepatotoxin in man. , 1988, Biochemical pharmacology.
[171] H. Freeman,et al. Neutropenia and Agranulocytosis in Patients Receiving Clozapine in the UK and Ireland , 1996, British Journal of Psychiatry.
[172] S. Shapiro,et al. Evaluation of Case Reports of Aplastic Anemia Among Patients Treated with Felbamate , 1997, Epilepsia.
[173] A. Saoudi,et al. Th2-type immunopathological manifestations induced by mercury chloride or gold salts in the rat: signal transduction pathways, cellular mechanisms and genetic control. , 2002, Autoimmunity reviews.
[174] An Animal Model of Hepatotoxicity Associated with Halothane Anesthesia , 1976, Anesthesiology.
[175] Yuan-Tsong Chen,et al. A marker for Stevens–Johnson syndrome , 2004 .
[176] S. Hanash,et al. Phenotypic and functional similarities between 5-azacytidine-treated T cells and a T cell subset in patients with active systemic lupus erythematosus. , 1992, Arthritis and rheumatism.
[177] M. Levy,et al. Role of Viral Infections in the Induction of Adverse Drug Reactions , 1997, Drug safety.
[178] C. D. Thompson,et al. Mechanisms of idiosyncratic drug reactions: the case of felbamate. , 2002, Chemico-biological interactions.
[179] S. Polley,et al. Advantages of glutamate dehydrogenase as a blood biomarker of acute hepatic injury in rats , 2002, Laboratory animals.
[180] A. M. Hoffman,et al. NEUTROPENIA FOLLOWING AMIDOPYRINE: PRELIMINARY REPORT , 1934 .
[181] I. James,et al. Predisposition to abacavir hypersensitivity conferred by HLA-B*5701 and a haplotypic Hsp70-Hom variant , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[182] M. Manns,et al. Experimental autoimmune hepatitis: Disease induction, time course and t‐cell reactivity , 1990, Hepatology.
[183] C. Mandet,et al. D-penicillamine-induced autoimmunity in Brown-Norway rats. Similarities with HgCl2-induced autoimmunity. , 1990, Journal of immunology.
[184] E. Amento,et al. Treating activated CD4+ T cells with either of two distinct DNA methyltransferase inhibitors, 5-azacytidine or procainamide, is sufficient to cause a lupus-like disease in syngeneic mice. , 1993, The Journal of clinical investigation.
[185] M. Coleman,et al. Aminoglutethimide-induced leucopenia in a mouse model: effects of metabolic and structural determinates. , 2003, Environmental toxicology and pharmacology.
[186] S. Belknap,et al. Serious Adverse Cutaneous and Hepatic Toxicities Associated With Nevirapine Use by Non–HIV-Infected Individuals , 2004, Journal of acquired immune deficiency syndromes.
[187] J. Shelhamer,et al. Pneumocystis carinii pneumonia: a comparison between patients with the acquired immunodeficiency syndrome and patients with other immunodeficiencies. , 1984, Annals of internal medicine.
[188] S. West,et al. D-penicillamine-induced lupus erythematosus. , 1990, Arthritis and rheumatism.
[189] M. Yaron,et al. Fatal aplastic anaemia and liver toxicity caused by D-penicillamine treatment of rheumatoid arthritis. , 1989, Annals of the rheumatic diseases.
[190] J. Gandolfi,et al. Characterization of the humoral immune response and hepatotoxicity after multiple halothane exposures in guinea pigs. , 1997, Drug metabolism reviews.
[191] R. Rodebaugh,et al. Metabolism of aminoglutethimide in the rat. , 1982, Drug metabolism and disposition: the biological fate of chemicals.
[192] M. Maeda,et al. Osteopontin as a mediator of NKT cell function in T cell-mediated liver diseases. , 2004, Immunity.